Novo Nordisk aims to launch several new blockbuster drugs in the next few years while expanding into further treatment areas

Shares in the company fell roughly 8% as its CEO laid out plans for new blockbuster drugs in the next few years.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading